CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-28 | EMSTER KURT VON Director | Sale | −88,011 | $19.79 | $1.7M | 1,951,359 |
| 2017-08-28 | Novak Rodger Chief Executive Officer | Option exercise | +17,692 | $1.81 | $32K | 1,232,697 |
| 2017-08-28 | Novak Rodger Chief Executive Officer | Sale | −17,692 | $20.06 | $355K | 1,215,005 |
| 2017-08-28 | Novak Rodger Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −17,692 | 50,401 | ||
| 2017-08-28 | Kulkarni Samarth Chief Business Officer | Sale | −23,154 | $20.09 | $465K | 110,893 |
| 2017-08-25 | EMSTER KURT VON Director | Sale | −14,913 | $19.52 | $291K | 2,039,370 |
| 2017-08-24 | EMSTER KURT VON Director | Sale | −7,868 | $19.23 | $151K | 2,054,283 |
| 2017-08-23 | EMSTER KURT VON Director | Sale | −7,035 | $18.53 | $130K | 2,062,151 |
| 2017-08-22 | EMSTER KURT VON Director | Sale | −10,954 | $18.53 | $203K | 2,069,186 |
| 2017-08-21 | EMSTER KURT VON Director | Sale | −1,250 | $18.51 | $23K | 2,080,140 |
| 2017-08-18 | EMSTER KURT VON Director | Sale | −1,900 | $18.53 | $35K | 2,081,390 |
| 2017-08-17 | EMSTER KURT VON Director | Sale | −13,593 | $18.74 | $255K | 2,083,290 |
| 2017-08-16 | EMSTER KURT VON Director | Sale | −20,548 | $19.27 | $396K | 2,096,883 |
| 2017-08-15 | EMSTER KURT VON Director | Sale | −25,586 | $19.53 | $500K | 2,117,431 |
| 2017-08-14 | EMSTER KURT VON Director | Sale | −29,983 | $19.64 | $589K | 2,143,017 |
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Conversion | +2,942,560 | 2,942,560 | ||
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Conversion | +211,567 | 3,154,127 | ||
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +66,500 | $14.00 | $931K | 3,220,627 |
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Conversion · Series A-3 Preferred Shares | −2,942,560 | 0 | ||
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Conversion · Series B Preferred Shares | −211,567 | 0 |
Page 61 of 62 · 1,221 trades